🚨 Now online 🚨 "Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan" to read the article in full click the link 👉 bit.ly/3u5EPEO

🚨 Essential read 🚨 Discover the pharmacoeconomic value of polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma. Click the link for the full article 👉 bit.ly/4bHYtI3

Excited to attend the #𝐖𝐨𝐫𝐥𝐝𝐄𝐏𝐀𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬 in Amsterdam next week, if you are attending and want to meet up to discuss Taylor & Francis's #healtheconomics journals, get in touch. Find out more about the congress here 👉 bit.ly/3IItuyp #Realworldevidence

I am excited to share the paper, "Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic #prostatecancer: results of a cost-effectiveness analysis", click the link for the full article👉 bit.ly/43n62jo

📢Have you read our latest supplement on #SystemicLupusErythematosus yet? To view the articles in full click the links below👇 bit.ly/3Tq6Rn9 #HEOR #healtheconomics #pharmacoeconomics #healthcare

Discover the costs of breast cancer recurrence after initial treatment for HR+, HER2−, high-risk early breast cancer, in this Journal of Medical Economics article. Full article available below 👇 bit.ly/4cUHX85 #breastcancer #healtheconomics #pharmacoeconomics #HEOR

🔔CMRO is recruiting for editorial board members!🔔 We're looking for a diverse range of editorial board members from across a variety of specialist areas. Please see the link below on how you can become a board member and our application process: think.taylorandfrancis.com/editor_recruit…

🚨 Article alert 🚨 Discover the impact that Ebola epidemics have on the daily operation of existing systems in Eastern Democratic Republic of the Congo, and what needs to be done to lessen these effects. Read the full article here 👉 bit.ly/3Uv4a5q Darb le Congolais

Hear global experts address topics surrounding #wholehealth and #HEOR in plenary sessions focused on measuring advancements in whole health, data linkage in #healthcare & related privacy constraints, & the impact of #AI on whole health, all @ #ISPORAnnual. ow.ly/805s50RhsU9

The list of expert speakers presenting at #ISPORAnnual is impressive! The annual conference convenes thousands of healthcare stakeholders from around the world to discuss topical themes in #HEOR. Learn more here>> ow.ly/hb4U50Rl8YK

Discussions occurring at #ISPORAnnual, the leading global conference for health economics and outcomes research, are advancing the science of #HEOR. Not attending in person? Use the Digital Conference Pass for post-conference session viewing. 👉ow.ly/HII250Rl95v

#ISPORAnnual has concluded after welcoming thousands of healthcare stakeholders from around the globe. Let’s continue the information sharing at #ISPOREurope! Submit your abstract and help shape the program! Details here 👉ow.ly/SAvx50RhqRK

Excited to share some 🚨 research 🚨 Discover the clinico-economic impacts of implementing polymerase chain reaction testing with Xpert Xpress compared to current testing strategies for #influenza like illnesses. Click the link for the full article 👉 bit.ly/3RDzVrn

🚨 Editors pick 🚨 My article of the week looks at how cost-effective #rimegepant an oral lyophilisate is compared to the best supportive care for the acute treatment of #migraine. To read the article click here 👉 bit.ly/3SkAVkc #Migrainetreatments #HEOR

📢 𝐉𝐮𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 📢 Discover the value of blood-based screening for #colorectalcancer in comparison to current screening modalities in our latest research article. Click the link to access the article 👉 bit.ly/3LRpTj4 #HEOR #healtheconomics #oncology

🚨 𝐄𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐫𝐞𝐚𝐝 🚨 Discover the cost drivers and where #kidneydialysis costs could be reduced in this important review, click the link to access 👉 bit.ly/4duHZ5Z #dialysis #hemodialysis #endstagerenaldisease #healtheconomics #pharmacoeconomics #HEOR

📢 Now online 📢 Read David Fox 💻🦔 and colleagues incredibly insightful article that looks at the real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell #lymphoma. Click the link for the full article 👉 bit.ly/4fAHyck #HEOR #Oncology

Delighted to share #newresearch with you. The article provides an insight into the reliability, validity and measurement equivalence of EQ-5D-5L questionnaire among #heartfailure patients in Malaysia. Click the link for the full article 👉 bit.ly/3AkgcqT #HEOR

Delighted to share that the 𝐉𝐨𝐮𝐫𝐧𝐚𝐥 𝐨𝐟 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜𝐬 is partnered with the 𝐖𝐨𝐫𝐥𝐝 𝐄𝐏𝐀 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬 in 2025. To discover more about the conference use the link below 👇 terrapinn.com/epa/IJME #healtheconomics #medicaleconomics #HEOR #RWE